Literature DB >> 2056538

Increased neutrophil mobilization and decreased chemotaxis during cortisol and epinephrine infusions.

J M Davis1, J D Albert, K J Tracy, S E Calvano, S F Lowry, G T Shires, R W Yurt.   

Abstract

Although hormones are putative mediators of neutrophil changes after injury, the effects of trauma-induced levels of plasma cortisol and epinephrine on circulating neutrophils have not been reported in humans. The dynamics of PMN mobilization and chemotaxis were evaluated during 19 infusions of epinephrine or cortisol or a combined infusion of both hormones in ten normal volunteers. Basal levels of epinephrine and cortisol increased during infusions to levels consistent with those reported following severe injury. Circulating neutrophil counts increased in parallel with plasma cortisol levels. Epinephrine mobilized the entire marginated pool of neutrophils, and the neutrophil half-life was extended from a normal of 6.6 hours to 10.4 hours by cortisol. Chemotaxis after six hours of epinephrine infusion was reduced compared with baseline chemotaxis. In four volunteers who had a second infusion of cortisol, chemotaxis was significantly depressed ten days after the infusion compared with baseline. From these data we conclude that stress levels of epinephrine mobilize the marginated pool of granulocytes into the circulating pool in a linear fashion, and cortisol raises the half-life of circulating neutrophils. Reduced neutrophil chemotaxis seen as a consequence of these infusions could account for some of the increased susceptibility to infection that occurs after major trauma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056538

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  24 in total

Review 1.  The role of epidural anesthesia and analgesia in surgical practice.

Authors:  Robert J Moraca; David G Sheldon; Richard C Thirlby
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

2.  Biomarkers of Psychological Stress in Health Disparities Research.

Authors:  Zora Djuric; Chloe E Bird; Alice Furumoto-Dawson; Garth H Rauscher; Mack T Ruffin; Raymond P Stowe; Katherine L Tucker; Christopher M Masi
Journal:  Open Biomark J       Date:  2008-01-01

3.  Evaluation of peripheral blood neutrophil leucocytes in lead-exposed workers.

Authors:  Luigi Di Lorenzo; Andrea Silvestroni; Maria Giuliana Martino; Tommaso Gagliardi; Marisa Corfiati; Leonardo Soleo
Journal:  Int Arch Occup Environ Health       Date:  2006-01-17       Impact factor: 3.015

4.  Effects of submaximal cycling and long-term endurance training on neutrophil phagocytic activity in middle aged men.

Authors:  A K Blannin; L J Chatwin; R Cave; M Gleeson
Journal:  Br J Sports Med       Date:  1996-06       Impact factor: 13.800

5.  Effect of lidocaine on neutrophil chemotaxis in newborn infants.

Authors:  A Gasparoni; D De Amici; L Ciardelli; M Autelli; M Regazzi-Bonora; A Bartoli; G Chirico; G Rondini
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

Review 6.  Glucocorticoids and central nervous system inflammation.

Authors:  Klaus Dinkel; William O Ogle; Robert M Sapolsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

7.  Modulation of adherence and chemotaxis of macrophages by norepinephrine. Influence of ageing.

Authors:  E Ortega; J J García; M De la Fuente
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

8.  A factor released by monocytes in the presence of dexamethasone stimulates neutrophil locomotion.

Authors:  S Chettibi; A J Lawrence; R D Stevenson
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

9.  Modulation of the adherence of human polymorphonuclear leukocytes by cadmium and nickel: sexual differences.

Authors:  M Macia; M Hernández
Journal:  Arch Environ Contam Toxicol       Date:  1995-07       Impact factor: 2.804

Review 10.  The management of postsurgical pain in the elderly population.

Authors:  J Richardson; K Bresland
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.